NOC/c	Notice of Compliance with Conditions
CDA-AMC	Canada’s Drug Agency
TLR	Time-Limited Recommendation
pCPA	pan-Canadian Pharmaceutical Alliance
pTAP	pan-Canadian Pharmaceutical Alliance Temporary Access Process
QN	Qualifying Notice
LoU	Letter of undertaking
LoI	Letter of intent
SUR	Submission Under Review
SBD	Summary Basis of Decision
HTA	Health technology assessment
OECD	Organisation for Economic Co-operation and Development
DLBCL	Diffuse Large B Cell Lymphoma